Based on a previous assay, tumor xenograft assay indicated that JYQHD effectively inhibited GC growth in vivo, while overexpression of COL12A1 counteracted the anticancer effect of JYQHD, and the tumor mass increased significantly compared with JYQHD group. Here, COL12A1 is linked to neoplasm.